Itraconazole and Secretion discharge - a phase IV clinical study of FDA data

Summary:

Secretion discharge is reported as a side effect among people who take Itraconazole (itraconazole), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Creon, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Secretion discharge when taking Itraconazole. It is created by eHealthMe based on reports of 12,233 people who have side effects when taking Itraconazole from the FDA, and is updated regularly.

What is Itraconazole?

Itraconazole has active ingredients of itraconazole. It is often used in fungal infection. eHealthMe is studying from 12,372 Itraconazole users. Check the latest studies of Itraconazole.

What is Secretion discharge?

Secretion discharge is found to be associated with 829 drugs and 784 conditions by eHealthMe. Check the latest studies of Secretion discharge.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

12,233 people reported to have side effects when taking Itraconazole.
Among them, 15 people (0.12%) have Secretion discharge.

Could Itraconazole cause Secretion discharge?

Among these 15 people:

How long have people been on Itraconazole when they have Secretion discharge? *

What is the gender of people who have Secretion discharge when taking Itraconazole? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Secretion discharge when taking Itraconazole? *

What are other drugs people take besides Itraconazole? *

What are other side effects people have besides Secretion discharge? *

Cough: 8 people, 53.33%
Dyspnea (difficult or laboured breathing): 7 people, 46.67%
Rash Erythematous (redness of the skin): 6 people, 40.00%
Lung Disorder (lung disease): 5 people, 33.33%
Oedema Peripheral (superficial swelling): 5 people, 33.33%
Chest Pain: 5 people, 33.33%
Bronchial Secretion Retention: 5 people, 33.33%
Drug Ineffective: 5 people, 33.33%
Dry Skin: 5 people, 33.33%
Pulmonary Congestion (congestion in the lungs): 5 people, 33.33%

What are the existing conditions these people have? *

Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 5 people, 33.33%
Asthma: 5 people, 33.33%
Joint Pain: 5 people, 33.33%
Back Pain: 5 people, 33.33%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 5 people, 33.33%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 33.33%
Cystic Fibrosis (disease of the secretary glands): 5 people, 33.33%
High Blood Pressure: 4 people, 26.67%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 4 people, 26.67%
Disseminated Tuberculosis: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Itraconazole and have Secretion discharge?

- Check whether Secretion discharge is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Itraconazole:

Itraconazole (12,372 reports)

Browse all side effects of Itraconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Secretion discharge:

Secretion discharge (829 drugs)

Browse all the conditions that are associated with Secretion discharge:

Secretion discharge (784 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on itraconazole (the active ingredients of Itraconazole) and Itraconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.